Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hepatitis

  Free Subscription


Articles published in BMJ

Retrieve available abstracts of 12 articles:
HTML format



Single Articles


    March 2023
  1. MAHASE E
    First hepatitis D medicine is given restricted approval in Scotland after US rejection.
    BMJ. 2023;380:p660.
    PubMed    


    February 2023

  2. Diagnosis and management of autoimmune hepatitis.
    BMJ. 2023;380:p330.
    PubMed    


  3. MURATORI L, Lohse AW, Lenzi M
    Diagnosis and management of autoimmune hepatitis.
    BMJ. 2023;380:e070201.
    PubMed     Abstract available


    July 2022
  4. WISE J
    Paediatric hepatitis is linked to infection with two viruses, studies find.
    BMJ. 2022;378:o1876.
    PubMed    


    June 2022
  5. SALMON R, Palmer S
    Recent hepatitis outbreak in children may have a foodborne toxin as its cause.
    BMJ. 2022;377:o1518.
    PubMed    


    May 2022
  6. CEVIK M, Rasmussen AL, Bogoch II, Kindrachuk J, et al
    Acute hepatitis of unknown origin in children.
    BMJ. 2022;377:o1197.
    PubMed    


  7. IACOBUCCI G
    Acute hepatitis is identified in more children, but cause remains elusive.
    BMJ. 2022;377:o1156.
    PubMed    


  8. MAHASE E
    Hepatitis: Ukrainian refugees should be offered vaccines and free treatment, says WHO.
    BMJ. 2022;377:o1132.
    PubMed    


    April 2022
  9. MAHASE E
    Hepatitis in children: What's behind the outbreaks?
    BMJ. 2022;377:o1067.
    PubMed    


  10. CHRISTIE B
    Scientists search for cause of hepatitis cases in children.
    BMJ. 2022;377:o982.
    PubMed    


    May 2021
  11. MEHTA SJ, Day SC, Norris AH, Sung J, et al
    Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial.
    BMJ. 2021;373:n1022.
    PubMed     Abstract available



  12. Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care.
    BMJ. 2021;373:n1130.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: